Lots of people are hearing about Novavax, the fourth COVID vaccine option in the U.S., for the first time, but it’s been authorized for use as a primary vaccine series since early 2022. Previously, it was only available for those who hadn’t received a mRNA vaccine—an alternative for those who either couldn’t or…
